Eigen Therapeutics is a biotechnology company on a mission to make therapies that make cancer easier to find and eliminate. Eigen is focused on the development of “priming” therapies, therapies that help targeted therapies reach their full potential by addressing cancer heterogeneity, making cancer cells more vulnerable and/or making healthycells more resilient to treatment. Eigen is building a high-throughput discovery platform to explore the space of priming therapies, leveraging proprietary machine learning algorithms to discover novel associations, new classes of drugs, and new potential therapies that change a cell's state to make it more vulnerable to a targeted therapy. The Eigen platform represents the intersection of biology and engineering, and includes robotic systems, laboratory operations software, and machine learning analysis pipelines—all developed in-house—with the ultimate goal of saving more lives.

Biotechnology

Eigen Therapeutics

Transon Nguyen

Kathryn Vanderlaag

This department focuses on advancing scientific knowledge through experimentation and innovation.

Research and Development

This department is responsible for setting the strategic direction and overall vision of the organization.

Eigen Therapeutics

Org chart

Teams

Research and Development

Executive Leadership

Offices

Eigen Therapeutics

Org chart

Teams

Research and Development

Executive Leadership

Offices

Related companies